Alter Pharma Group
Drug Stores & Pharmacies · Belgium · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Square Marie Curie 50, Anderlecht, 1070,...Phone Number
+32 25266410Website
www.alterpharmagroup.beRevenue
$18 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Alter Pharma Group
Alter Pharma Group is a company that specializes in the distribution of pharmaceutical products to hospitals, pharmacies, retirement homes, and wholesalers. The company is based in Anderlecht, Belgium.Explore more
Alter Pharma Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alter Pharma Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Alter Pharma Group is spiking on competitors!
Check if Alter Pharma Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Alter Pharma Group has new funding data
Earning: See what the market has to say on Alter Pharma Group recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Alter Pharma Group
Alter Pharma Group, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Alter Pharma Group launches new products
Website visits: Recent activity has been detected on your website
Click to see if Alter Pharma Group had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Alter Pharma Group
Find 3 more new buyers
Company Profile Activity
Activity Insights
Alter Pharma Group is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Alter Pharma Group is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Alter Pharma Group.
Alter Pharma Group Tech Stack
A closer look at the technologies used by Alter Pharma Group
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Alter Pharma Group News & Media
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce Yet Another “First Cycle” FDA Approval for an Abbreviated New Drug Application (ANDA), Dexmedetomidine Hydrochloride Injection
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that it has received FDA approval for its generic version of Precedex®, Dexmedetomidine Hydrochloride Injection 4mcg/ml in 50mL and 100mL, and plans to launch in the very near future. Dexmedetomidine Hydrochloride Injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. It should be administered byMilla Pharmaceuticals Inc. and the Alter Pharma Group Announce Launch of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers by Their Partner Athenex Pharmaceutical Division (APD)
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that its partner, Athenex Pharmaceutical Division (APD), has just started to commercialize its abbreviated new drug application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its Generic Version of Magnesium Sulfate in Water for Injection, 2 g/50 mL (40 mg/mL), 4 g/100 mL (40 mg/mL) and 4 g/50 mL (80 mg/mL), in Non-PVC, Single-Patient Use Containers (MagnesiumMilla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced it has filed its ANDA Application with Paragraph IV Certification on July 20th, 2022 and received a Paragraph IV Acknowledgement Letter and Receipt from FDA on August 31st, 2022. After providing the requisite notice to the NDA holder, the Company reports that the NDA holder has not commenced legal action against the Company within the statutory time frame. It is also worthThird ANDA Approval for Milla Pharmaceuticals Inc. and the 4th U.S. Approval for the Alter Pharma Group.
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announces U.S. Food and Drug Administration (FDA) has granted approval to the Company's Abbreviated New Drug Application (ANDA) for a generic version of Mestinon® (Pyridostigmine Bromide Syrup) 60 mg/5mL. Pyridostigmine Bromide Syrup is indicated for symptomatic treatment of myasthenia gravis. Myasthenia gravis is a neuromuscular disorder primarily characterized by muscle weakness and rapid m
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alter Pharma Group
Sign Up For FreeTo access detailed company insights
Alter Pharma Group is a company that specializes in the distribution of pharmaceutical products to hospitals, pharmacies, retirement homes, and wholesalers. The company is based in Anderlecht, Belgium.... Read More
